ABRYSVO™ RSV vacc, preF A and preF B/PF 120 mcg / 0.5 mL Injection 0.5 mL

Name: Respiratory Syncytial Virus Vaccine
Brand: ABRYSVO™

ABRYSVO, RESPIRATORY SYNCYTIALVACCINE 120MCG 0.5ML (5/CT)

McKesson #

1234144

Manufacturer #

00069034405

Brand

ABRYSVO™

Manufacturer

Pfizer (RSV Vaccines)

Country of Origin

Unknown

Application

Respiratory Syncytial Virus Vaccine

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

54296

Generic Drug Name

RSV vacc, preF A and preF B/PF

NDC Number

00069034405

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

120 mcg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201600

Volume

0.5 mL

ABRYSVO™ is a vaccine indicated for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV)
ABRYSVO is supplied in a kit that includes a vial of Lyophilized Antigen Component (NDC 0069-0207-01), a prefilled syringe containing Sterile Water Diluent Component (NDC 0069-0250-01) and a vial adapter
The Lyophilized Antigen Component is reconstituted with the Sterile Water Diluent Component to form a single dose of ABRYSVO
The vial stopper and the tip cap and rubber plunger of the prefilled syringe are not made with natural rubber latex
Carton: 5 kits
ABRYSVO is a vaccine indicated for: Active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age
ABRYSVO is a vaccine indicated for: Active immunization for the prevention of LRTD caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older